Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-01 5:14 pm Sale |
2020-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Novartis Bioventures Ltd | 1,641,146 7.700% |
-126,995 (-7.18%) |
Filing History |
| 2021-01-20 4:30 pm Sale |
2021-01-19 | 13D | Bicycle Therapeutics plc BCYC |
Vertex Global HC Fund I Pte. Ltd. | 883,475 4.150% |
-737,693 (-45.50%) |
Filing History |
| 2020-12-07 5:06 pm Sale |
2020-11-05 | 13D | Bicycle Therapeutics plc BCYC |
GLAXOSMITHKLINE PLC | 1,894,831 8.900% |
-20,444 (-1.07%) |
Filing History |
| 2020-11-12 09:11 am Unchanged |
2020-11-05 | 13D | Bicycle Therapeutics plc BCYC |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 9.200% |
0 (Unchanged) |
Filing History |
| 2020-09-15 4:32 pm Purchase |
2020-09-14 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 1,102,976 5.700% |
1,102,976 (New Position) |
Filing History |
| 2020-07-20 09:51 am Unchanged |
2020-06-30 | 13D | Bicycle Therapeutics plc BCYC |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 10.800% |
0 (Unchanged) |
Filing History |
| 2020-07-13 4:28 pm Purchase |
2020-07-02 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 1,144,633 6.300% |
1,144,633 (New Position) |
Filing History |